Cathleen Melendez

New Tests & Research in the Fight Against COVID-19 & Cancer: September 2020 News

In recent weeks, we’ve seen further advances in the molecular diagnostic sector’s response to the COVID-19 pandemic. Labs are scaling to meet the demand for more testing, and the FDA has provided emergency authorization for new types of tests. The sector also continues to push forward with new cancer tests that will have a significant impact on patient outcomes. COVID-19 […]

Read More

The Right Consultant Can Help You Improve Profitability and Growth

Optimizing an NGS Clinical Diagnostic laboratory for growth is no small task. Laboratory and technical leads, and other stakeholders, understand full well the complexity of the business and recognize the risk in hiring the wrong consultants to help them modernize their software and update their technology. That doesn’t mean it’s better to use internal development resources, though. The right consultants […]

Read More

How to Accelerate Your Laboratory Accreditation

In my previous post, I described the challenges of certification, accreditation, and federal approvals, and how software can have a huge impact on the speed and ease with which your team goes through the process. For forward-thinking laboratory and technical leaders, however, regulatory approvals can also offer an opportunity to make software improvements that will help your business respond to […]

Read More

Laboratories Boost Capacity to Support Widespread Testing: August 2020 News

In our previous recap of industry news, we looked at the exciting partnerships and collaborations driving change, C-Suite and Board additions, and mergers and acquisitions. The Molecular Diagnostic Industry continues to innovate and grow, with laboratories and other industry partners working together to expedite COVID-19 testing and advance the community’s knowledge of the coronavirus. At the same time, clinical labs […]

Read More

Laboratory Accreditation: What’s Software Got To Do With It?

Certification, accreditation, and federal approvals are a vital part of the business of running a clinical diagnostic lab. Many laboratory managers assume it means miles of red tape and numerous roadblocks. But that’s not necessarily true. In fact, it can be a fantastic opportunity. If you approach it with the right mindset, you could make improvements that have a lasting […]

Read More

Future-Proofing Your NGS Clinical Diagnostic Lab & LIMS

In my previous post, I described the complex challenges NGS Clinical Diagnostic laboratories face because of legacy software. To recap, these include limitations in usability and efficiency, higher costs than labs generally understand, the difficulties that arise when you need to replace key personnel, and the lack of specialized software expertise in internal development teams. For laboratory and technical leads […]

Read More